The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales - but only for patients who have tried all other options. Endometriosis affects 1.5 million women in the UK, causing pain and extreme tiredness as a result of tissue similar to the womb lining growing elsewhere in the body.

A new combination pill, relugolix–estradiol–norethisterone, has been approved for treating endometriosis on the NHS. This marks the first long-term, daily oral treatment for the condition, offering a significant advancement in endometriosis management.

Managing debilitating symptoms for a condition that has no cure or universal treatment is almost impossible – and it's the reality for the 1.5 million women and those born female with endometriosis in the UK.

The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating condition.